CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
about
Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem CellsTargeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus.IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axisCXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.Caloric restriction and the adipokine leptin alter the SDF-1 signaling axis in bone marrow and in bone marrow derived mesenchymal stem cells.CXCR7 expression in nasopharyngeal carcinoma tissues correlates with disease severity.Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma modelElevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma.Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.Atypical chemokine receptors in cancer: friends or foes?Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets.CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.CXCR7 as a chemokine receptor for SDF-1 promotes gastric cancer progression via MAPK pathways.CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.Risk of fatigue in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus: a comparative meta-analysis.
P2860
Q28078154-E8C2A30D-405F-47D6-97E7-8FED43A663C7Q35063752-C5C15C14-D359-4FA5-A133-693733C951DBQ35578377-01C66A92-8AE7-46B0-972C-0DFE2DC95925Q36291113-758D65FF-9117-41E6-9BD9-5C8DD0EA6114Q36445542-E2FD7350-05EA-496A-94CB-5C89AFE2F040Q36493066-9B47ED01-02E1-4635-820C-AC644D80D7D7Q36728282-3FC3DB78-1E96-4F0B-92C9-E95BFF27CE61Q37046500-3EB954FD-9CFD-4895-A5C3-3D7ED4EFFD24Q38284921-62562CC8-6A52-4F73-8D0B-DD9EEC59234FQ38642842-D6BCD16C-B422-49B9-A134-44D817E3CDA5Q38747771-D2271703-90DD-4319-8732-E838E6A4A277Q38763251-FFDAE341-2CA6-40F0-A86B-435E9CD0758CQ38789650-2B84C0E7-8025-41C1-9662-11A1054DCBD7Q46106579-D90813EF-FE59-4FB6-915A-2F0C6CF886CCQ51102743-C54F4EBF-7C8D-4A2F-B7C0-2034F5326BCCQ51116329-5174D388-4E30-4374-B08D-76C8C4DC16C3Q51615425-C7FB3CCE-F2A3-49D3-A663-CFE4543132D7Q53809725-570FE7C7-7AE5-495F-9F56-FBB624A0D5D1
P2860
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
@en
type
label
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
@en
prefLabel
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
@en
P2093
P2860
P50
P356
P1476
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
@en
P2093
A Grimaldi
E Antignani
M Nanayakkara
S Santagata
P2860
P356
10.1038/CDDIS.2014.269
P50
P577
2014-07-03T00:00:00Z